Qsymia 7.5 MG-46 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9KQ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,217
Award facts
- Contract value 100% obligated
- $1,216.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,216.73 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) on January 12, 2026, with completion expected by January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Qsymia is a prescription weight-loss medication combining phentermine and topiramate, used in military and federal healthcare settings to support patient treatment protocols.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031. This prime contract vehicle enables the pharmaceutical distributor to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including delivery to military treatment facilities, veterans' healthcare systems, and other federal medical institutions. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen maintains a significant role in the federal medical supply chain and has demonstrated consistent capability to fulfill open competition federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9KQ6?
SPE2DR26F9KQ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F9KQ6 worth?
The government has obligated $1,217 on SPE2DR26F9KQ6.
Is contract SPE2DR26F9KQ6 an order under another contract?
Yes. SPE2DR26F9KQ6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KQ6 competed?
The extent of competition for SPE2DR26F9KQ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award